Clinical Trial Update: Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

View source ↗

Summary

A completed trial assessing the tolerability of Sifrol (pramipexole) in ambulatory patients with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sifrol (ropinirole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED